You just read:

AcelRx Pharmaceuticals to Announce Topline Results in Phase 3 Study of ARX-04 in Patients with Post-Operative Moderate-to-Severe Acute Pain

News provided by

AcelRx Pharmaceuticals, Inc.

Sep 14, 2016, 16:01 ET